Bioseparations Exam #1 Study Guide
1. Classification of Bioproducts
a. Definition
Bioproducts: Products derived from biological sources or manufactured using biological
systems (e.g., microorganisms, plant or animal cells)
b. Classes and Examples
Small Molecules (<1 kDa)
Examples: Amino acids, antibiotics, vitamins, organic acids
Large Molecules (1-1000 kDa)
Examples: Proteins, enzymes, antibodies, nucleic acids
Particles (>1000 kDa)
Examples: Cells, viruses, organelles, inclusion bodies
i. Primary vs. Secondary Metabolites
Primary Metabolites Secondary Metabolites
Essential for growth and reproduction Not essential for growth
Produced during exponential growth phase Usually produced during stationary phase
Examples: amino acids, nucleotides, lipids, Examples: antibiotics, pigments, toxins,
carbohydrates alkaloids
ii. Structural Differences and Impact on Bioseparations
Small molecules: Generally stable, less sensitive to process conditions, can withstand
harsh separation methods
Large molecules (proteins, nucleic acids): Often sensitive to temperature, pH, shear,
and solvents; require gentler separation techniques
Particles: Most sensitive to shear forces and require specialized handling techniques
c. Macromolecules, Monomers, and Basic Properties
Proteins
Monomer units: Amino acids
Properties: Amphoteric, sensitive to pH and temperature, complex 3D structure
Nucleic acids
Monomer units: Nucleotides
Properties: Negatively charged, sensitive to enzymes, UV light
Polysaccharides
Monomer units: Monosaccharides
Properties: Often water-soluble, can form gels, variable charge
Lipids
Monomer units: Fatty acids, glycerol
Properties: Hydrophobic, form micelles/bilayers in water
d. Protein Properties
i. Protein Structure
Primary structure: Linear sequence of amino acids connected by peptide bonds
o Stabilized by covalent peptide bonds
Secondary structure: Regular local structures (α-helices, β-sheets)
o Stabilized by hydrogen bonds between backbone atoms
Tertiary structure: Overall 3D folding of a single polypeptide chain
o Stabilized by hydrophobic interactions, hydrogen bonds, ionic bonds,
disulfide bridges
Quaternary structure: Assembly of multiple folded protein subunits
o Stabilized by same forces as tertiary structure plus interactions between
subunits
ii. Protein Folding
Driven by minimizing free energy
Hydrophobic residues tend to fold inward (hydrophobic core)
Hydrophilic residues tend to face outward
Surface properties impact:
o Solubility
o Charge-based separations (ion exchange)
o Hydrophobic interaction separations
o Affinity-based separations
iii. Protein Denaturation
Factors that must be controlled during bioseparation:
o Temperature (avoid excessive heat)
o pH (maintain within stable range)
o Organic solvents (can disrupt hydrophobic interactions)
o Chaotropic agents (urea, guanidinium)
o Mechanical shear forces
o Oxidizing/reducing agents (affect disulfide bonds)
o Surface interactions (air-liquid interfaces)
iv. Monoclonal Antibodies
Y-shaped glycoproteins (~150 kDa)
Highly specific binding to target antigens
Important characteristics:
o High specificity and affinity
o Two identical antigen-binding sites (Fab regions)
o Constant region (Fc) can be used for purification
o Glycosylation patterns affect stability and function
o Relatively stable in neutral pH conditions
o Sensitive to aggregation during processing
2. Stages of Downstream Processing
Stage 1: Solid-Liquid Separation
Remove solids (cells, cell debris) from liquid phase containing product
Stage 2: Product Isolation
Separate product from bulk solution components, concentrate
Stage 3: Product Purification
Remove similar contaminants, achieve high purity
Stage 4: Product Polishing
Remove trace impurities, ensure final product quality
Stage 5: Formulation
Prepare final product in suitable form for storage and use
3. Main Challenges for Separation of Bioproducts
Low concentrations in starting material
Complex mixtures with similar contaminants
Sensitivity to processing conditions (temperature, pH, shear)
Product instability (denaturation, aggregation, degradation)
Biological activity must be maintained throughout
Scale-up challenges
Regulatory requirements for purity and safety
4. General Strategies and Guidelines for Bioseparation
Process Development
Start with gentlest methods, progress to more selective ones
Minimize number of steps to improve overall yield
Consider product stability at each step
Exploit largest differences between product and contaminants
Consider scale-up requirements early
Develop analytical methods in parallel
Design for reproducibility and robustness
Balance purity, yield, and cost requirements
5. Bioseparation Processes for Different Product Locations
a. Product is Cells
Cultivation → Solid-liquid separation (centrifugation/filtration) → Cell concentration →
Washing → Formulation
Minimal processing, focus on maintaining cell viability
b. Intracellular Product
Cultivation → Harvest → Cell disruption → Debris removal → Isolation → Purification
→ Polishing → Formulation
Requires cell lysis step and management of cellular contaminants
c. Extracellular Product
Cultivation → Solid-liquid separation → Isolation → Purification → Polishing →
Formulation
No cell disruption needed, but typically lower initial concentration
6. Key Considerations for Bioseparation
Consideration Impact on Process Design
Intracellular vs. Determines need for cell disruption steps
Extracellular
Product Stability Influences process conditions, step order, and speed
Viscosity Affects filtration, centrifugation, and mass transfer rates
Contaminants Determines selection of separation techniques
Product Specifications Sets requirements for final purity and quality
7. Properties Exploited for Isolation and Purification
Property Separation Techniques
Size Filtration, ultrafiltration, gel filtration, dialysis
Charge Ion exchange chromatography, electrophoresis, isoelectric focusing
Hydrophobicity Hydrophobic interaction chromatography, reversed-phase
chromatography
Solubility Precipitation, crystallization, salting out
Biospecific Affinity chromatography, immunoprecipitation
Interactions
Size Filtration, ultrafiltration, gel filtration, dialysis
8. Process and Product Quality Parameters
a. Specific Activity
Definition: Activity per unit mass of total protein
Calculation: Specific Activity = Total Activity (units) / Total mass/protein (mg)
Units: Units/mg protein
b. Concentration Factor
Definition: Ratio of final concentration to initial concentration
Calculation: CF = Final Concentration / Initial Concentration
Dimensionless
c. Purity
Mass-based: Mass of desired product / Total mass
Activity-based: Activity of desired product / Total activity of all components
Mass (protein): amt of protein product / amt of total protein
d. Fold Purification
Definition: Ratio of purity after and before purification
Calculation: Fold Purification = Final purity / Initial purity
Dimensionless
e. Yield
Definition: Percentage of product recovered after a step
Calculation: Yield (%) = (Mass or Activity Recovered / Initial Mass or Activity) × 100%
f. Separation Factor
Definition: Ratio of product/contaminant concentration ratios before and after treatment
Calculation: α = (conc prod/conc contam)after / (conc prod/conc contam)before
Dimensionless
9. Process Development Criteria
a. Required Purity
Depends on application (higher for therapeutics)
Regulatory requirements (FDA, EMA)
Safety considerations
Consistency requirements
b. Product Cost
Cost of raw materials
Number of processing steps
Equipment and facility costs
Scale of production
Yield losses
c. Scalability
Equipment availability at larger scales
Consistent performance across scales
Heat and mass transfer limitations
Process control capabilities
d. Reproducibility
Batch-to-batch consistency
Robust process parameters
Well-defined raw materials
Validated analytical methods
e. Robustness
Tolerance to variations in inputs
Process control strategy
Defined acceptable ranges for critical parameters
Failure mode analysis
10. Product Specifications
Identity (confirms it is the correct product)
Purity (absence of process-related impurities)
Potency (biological activity)
Safety (absence of harmful contaminants)
Stability (shelf-life under specified conditions)
Physical attributes (appearance, solubility)
11. Drug Substance vs. Drug Product
Drug Substance Drug Product
Active pharmaceutical ingredient (API) Final formulated product
Bulk purified material Includes excipients, stabilizers
Intermediate in manufacturing Finished dosage form
12. Assay Attributes and Purpose
a. Precision
Definition: Closeness of agreement between repeated measurements
Determination: Calculate standard deviation or relative standard deviation of replicate
measurements
Purpose: Ensures reproducible results
b. Accuracy
Definition: Closeness of measured value to true value
Determination: Compare to reference standards, recovery studies
Purpose: Ensures correct quantification
c. Range
Definition: Concentration interval with acceptable accuracy and precision
Determination: Validate at multiple concentration levels
Purpose: Defines useful working concentrations
d. Specificity
Definition: Ability to measure target analyte without interference
Determination: Test with potential interfering substances
Purpose: Ensures measurement of only the intended analyte
e. Linearity, Limit of Detection, Limit of Quantitation
Linearity: Linear relationship between signal and concentration
o Determined by calibration curve and regression analysis
Limit of Detection (LOD): Lowest detectable concentration
o Determined as signal-to-noise ratio ≥ 3
Limit of Quantitation (LOQ): Lowest concentration quantifiable with acceptable
precision
o Determined as signal-to-noise ratio ≥ 10
f. Robustness
Definition: Capacity to remain unaffected by small variations in method parameters
Determination: Deliberate small changes to method conditions
Purpose: Ensures reliability during normal use
13. Analysis Methods
a. Analysis Techniques
i. Biological Activity Analysis
Method Principle Advantages Disadvantages
Animal model Test in Most thorough, best Long/slow, poor precision
animals evidence of side effects & reproducibility, resource
(administer) intensive
Cell-line Measures Reflects in-vivo Can be imprecise b/c of
derived biological activity, faster, less variances of living cells
bioassays response in expensive, less waste
cells
In-vitro Measures Simple, fast, sensitive, Overly simplified (used
biochemical interaction accurate when mechanisms and in-
assay with target vivo activity is known well)
ii. Protein Assays
General considerations: type of materials (solids = Kjeldhal) & compatibility w/
sample, buffer, conc., proteins, (no interference).
Method Principle Considerations
Kjeldahl Used for solids/raw materials; not
Total nitrogen converted to protein
Assay specific to proteins
Bradford Blue dye (Coomassie) binds to basic Quick, sensitive; interferes with
Assay amino acids some buffers and detergents
Cu²⁺ reduced to Cu⁺ by peptide bonds, Compatible with detergents;
BCA Assay
forms complex with bicinchoninic acid interferes with reducing agents
Lowry Reaction between Cu²⁺ in alkaline Sensitive; many interfering
Assay tartrate and peptide bonds substances
iii. Gel Electrophoresis
Type Description Application
Uses reducing agents (β-mercaptoethanol, Separates subunits, analyzes
Reducing
DTT) to break disulfide bonds individual chains
Analyzes intact protein
Non-reducing No reducing agents; disulfide bonds intact
structure
No SDS, proteins retain folded structure Maintains activity, separates
Native
and native charge based on charge and size
Isoelectric Separates based on isoelectric point in pH High resolution for charge
Focusing gradient variants
2-D Isoelectric focusing followed by size sep Characterization of sample
iv. Western Blot
Combines gel electrophoresis with antibody detection
Identifies specific proteins in complex mixtures
Provides information on size and approximate quantity
v. ELISA (Enzyme-Linked Immunosorbent Assay)
Uses antibodies conjugated to enzymes for detection (bind antibody to plate)
Highly sensitive and specific
Quantitative or qualitative detection of proteins (low concentrations)
vi. HPLC (High-Performance Liquid Chromatography)
Separates components based on different properties
Types: size exclusion, ion exchange, reversed-phase, etc.
Quantitative, reproducible, high resolution, only analytical
vii. Absorbance Measurements
Protein absorbance at 280 nm (due to aromatic amino acids)
Peptide absorbance at 192 nm (peptide bonds)
Beer's Law: A = εcl
o A = absorbance
o ε = molar absorptivity (extinction coefficient)
o c = concentration
o l = path length
Extinction Coefficient Calculation:
o ε = A / (c × l)
o For proteins: can estimate from amino acid composition
Concentration Calculation:
o c = A / (ε × l)
o For diluted samples: c (original) = c (measured) × dilution factor
b. Endotoxin Evaluation
Endotoxin: Lipopolysaccharides from gram-negative bacteria
Importance: Can cause fever, inflammation, shock when injected
Detection Methods:
o LAL (Limulus Amebocyte Lysate) assay
o Rabbit pyrogen test (animal-based)
o In vitro biochemical assays using synthetic substrates
c. Microbiological Assays
Sterility Tests: Verify absence of viable organisms
Bioburden Tests: Quantify microbial contamination level
Importance: Ensures product safety and quality
What They Measure: Presence/absence or quantity of microorganisms
d. Purity Evaluation
Three Ways to Define Purity:
1. Mass-based: Mass of product / total mass
2. Activity-based: Activity of product / total activity
3. Relative purity: Ratio of specific contaminant to product
Method Selection Based on Definition:
o Numerator (product quantification): HPLC, specific assays, electrophoresis
o Denominator (total mass/activity): Total protein assays, total activity assays
e. Beer's Law for Protein Concentration
Formula: A = εcl
Pure Protein Concentration: c = A / (ε × l)
Extinction Coefficient: Specific to each protein
Typical Values:
o For proteins at 280 nm: 0.5-1.5 L/g·cm
o For IgG: approximately 1.4 L/g·cm at 280 nm
14. Cell Lysis
a. Cell Structure Differences
Prokaryotes vs. Eukaryotes
Prokaryotes: 0.1-10 μm, no nuclear membrane, few/simple organelles, often have cell
wall
Eukaryotes: 10-100 μm, nuclear membrane present, many/complex organelles, cell wall
usually absent (except plants)
Bacteria Types
Gram-negative: Thin peptidoglycan layer, outer membrane; easier to lyse
Gram-positive: Thick peptidoglycan layer, no outer membrane; more difficult to lyse
b. Selection of Cell Lysis Method
Gram-negative bacteria
Recommended Methods: Osmotic shock, detergents, moderate mechanical methods
Considerations: Relatively easy to disrupt
Gram-positive bacteria
Recommended Methods: Stronger mechanical methods, enzymatic (lysozyme)
Considerations: More force required
Yeast/Fungi
Recommended Methods: Mechanical disruption, enzymatic
Considerations: Tough cell walls
Mammalian cells
Recommended Methods: Gentle methods (osmotic shock, detergents)
Considerations: No cell wall, easily damaged
c. Osmotic Pressure Calculation
Transmembrane Pressure: ΔP = RT(Ci - Co)
o R = gas constant
o T = temperature
o Ci = internal osmolarity
o Co = external osmolarity
Cell Breaking Condition: ΔP > cell wall mechanical strength
d. Osmolarity Calculation
Osmolarity = Σ(concentration × number of ions)
Example: 1M NaCl = 2 osmolar (Na⁺ and Cl⁻)
e. Cell Lysis Methods
Chemical Methods
Method Mechanism Considerations
Gentle, may interfere with
Detergents Solubilize membrane lipids
purification
Osmotic
Water influx causes cell rupture Gentle, incomplete lysis
shock
Specific, expensive, adds
Enzymatic Specific degradation of cell wall
contaminants
Extr. Proteins, remove lipids and Denature protein, special
Solvents
nucleic acids handling
Mechanical Methods
Method Mechanism Considerations
Shear forces through
Sonication Efficient, scalable, heat generation
valve
Homogenizatio Cavitation from Effective for tough, high mech stress =
n ultrasound denaturation
Bead milling Collision with beads Good for tough cells, heat, specialized equip
f. Valve-type Homogenizer Relationships
Disruption Equation: ln(1-R) = -KNPⁿ
o R = fraction disrupted
o N = number of passes
o P = pressure
o K, n = constants
Temperature Impact: Higher temperatures generally increase disruption efficiency but
may damage product
Number of Passes Impact:
o More passes → more complete disruption
o More passes → smaller debris particles
o Optimal range: typically 2-5 passes (balances disruption vs. fine debris
generation)
15. Flocculation
a. Purpose and Basic Principles
Purpose: Aggregate small particles into larger flocs for easier separation
Principles:
o Balance between attractive and repulsive forces
o Attractive: van der Waals, hydrophobic interactions
o Repulsive: electrostatic repulsion, hydration
b. Electrical Double Layer
i. Structure
Stern Layer: Tightly bound counter-ions at particle surface
Diffuse Layer: More loosely associated counter-ions
Hydration Layer: Water molecules oriented by surface charge
Zeta Potential: Electric potential at the slipping plane (boundary of mobile fluid)
ii. Importance
Determines stability of colloidal suspensions
Affects particle-particle interactions
Influences separation efficiency
iii. Impact on Downstream Processing
Stable colloids (high zeta potential) resist separation
Neutralization of surface charge facilitates aggregation
Flocculation reduces fine particles that clog filters
iv. Requirements for Flocculation
Reduction of repulsive forces (charge neutralization)
Addition of bridging polymers or multivalent ions
Optimal mixing conditions
v. Thickness Factors
Debye Radius: Characteristic thickness of double layer
Secondary Minimum: Distance where weak attraction occurs
Formula: κ⁻¹ = √(εₒεᵣRT/2F²I)
o κ⁻¹ = Debye radius
o εₒεᵣ = dielectric constant
o I = ionic strength
o F = Faraday constant
vi. Factors Affecting Debye Radius
Temperature: Higher temperature → larger radius
Ion Concentration: Higher concentration → smaller radius
Ion Charge: Higher charge → smaller radius
c. DLVO Theory
Critical Flocculation Concentration (CFC): Minimum concentration of flocculant
Calculation: CFC ∝ 1/z⁶ (z = valence of counter-ion)
needed
Temperature Impact: Higher temperature requires higher CFC
Counterion Charge Impact: Higher charge dramatically reduces CFC
d. Flocculants
Schultze-Hardy Rule: CFC ∝ 1/z⁶
For example:
o If monovalent ion CFC = C
o Divalent ion CFC ≈ C/64
o Trivalent ion CFC ≈ C/729